Precise utilisation of triple therapy inhalers can reduce the burden of asthma in Singapore

On 16 April 2024, GSK organised the Trelegy Asthma: Release From Constriction seminar in Singapore. The event featured talks from distinguished experts, Associate Professor Loo Chian Min and Professor Simon Bowler who provided insights on the disease burden of asthma in Singapore and how a precision medicine approach with the single-inhaler triple therapy, Trelegy Ellipta, can improve lung function and symptom control in patients with uncontrolled asthma. The session was chaired by Dr Kenneth Chan.